Advertisement

Index by author

August 01, 1997; Volume 282,Issue 2

  1. Athanikar, Jyothi

    1. Receptor Specificity of Retinoid-Induced Epidermal Hyperplasia: Effect of RXR-Selective Agonists and Correlation with Topical Irritation
      Scott M. Thacher, Andrew M. Standeven, Jyothi Athanikar, Scott Kopper, Oliver Castilleja, Maria Escobar, Richard L. Beard and Roshantha A. S. Chandraratna
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 528-534;

  2. Aubrecht, Jiri

    1. Tissue Specific Toxicities of the Anticancer Drug 6-Thioguanine Is Dependent on the Hprt Status in Transgenic Mice
      Jiri Aubrecht, Mary E. P. Goad and Robert H. Schiestl
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1102-1108;

  3. Axelson, James E.

    1. Estimation of Transplacental and Nonplacental Diphenhydramine Clearances in the Fetal Lamb: The Impact of Fetal First-Pass Hepatic Drug Uptake
      Sanjeev Kumar, George R. Tonn, Eddie Kwan, Caroline Hall, K. Wayne Riggs, James E. Axelson and Dan W. Rurak
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 617-632;

  4. Badiani, Aldo

    1. Enduring Enhancement of Amphetamine Sensitization by Drug-Associated Environmental Stimuli
      Aldo Badiani, Dianne M. Camp and Terry E. Robinson
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 787-794;

  5. Barbone, A. G.

    1. Evaluation of the Antiinflammatory Activity of a Dual Cyclooxygenase-2 Selective/5-Lipoxygenase Inhibitor, RWJ 63556, in a Canine Model of Inflammation
      T. Kirchner, D. C. Argentieri, A. G. Barbone, M. Singer, M. Steber, J. Ansell, S. A. Beers, M. P. Wachter, W. Wu, E. Malloy, A. Stewart and D. M. Ritchie
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1094-1101;

  6. Bartok, Rory E.

    1. Sex Differences in Opioid Antinociception
      Rory E. Bartok and Rebecca M. Craft
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 769-778;

  7. Beard, Richard L.

    1. Receptor Specificity of Retinoid-Induced Epidermal Hyperplasia: Effect of RXR-Selective Agonists and Correlation with Topical Irritation
      Scott M. Thacher, Andrew M. Standeven, Jyothi Athanikar, Scott Kopper, Oliver Castilleja, Maria Escobar, Richard L. Beard and Roshantha A. S. Chandraratna
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 528-534;

  8. Beers, S. A.

    1. Evaluation of the Antiinflammatory Activity of a Dual Cyclooxygenase-2 Selective/5-Lipoxygenase Inhibitor, RWJ 63556, in a Canine Model of Inflammation
      T. Kirchner, D. C. Argentieri, A. G. Barbone, M. Singer, M. Steber, J. Ansell, S. A. Beers, M. P. Wachter, W. Wu, E. Malloy, A. Stewart and D. M. Ritchie
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 1094-1101;

  9. Bernat, A.

    1. V2 Receptor Antagonism of DDAVP-Induced Release of Hemostasis Factors in Conscious Dogs
      A. Bernat, P. Hoffmann, A. Dumas, C. Serradeil-Le Gal, D. Raufaste and J. M. Herbert
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 597-602;

  10. Bevan, P.

    1. Regulation of Neuronal and Recombinant GABAA Receptor Ion Channels by Xenovulene A, a Natural Product Isolated fromAcremonium strictum
      P. Thomas, H. Sundaram, B. J. Krishek, P. Chazot, X. Xie, P. Bevan, S. J. Brocchini, C. J. Latham, P. Charlton, M. Moore, S. J. Lewis, D. M. Thornton, F. A. Stephenson and T. G. Smart
      Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 513-520;
« Previous (Pages : 1 2 3 4 5 6 7 ... 34) Next »
Back to top

In this issue

Advertisement